Help people with diabetes improve their control of glucose and other cardiovascular risk factors. Also provide optimal control to people with alterations in thyroid function or prevent fractures in women with osteoporosis.

English, Español

• Degree in Health Sciences. Universidad de Costa Rica. 1977

• Post Doctoral Fellowship on Diabetes and Lipid Metabolism - Toronto General Hospital, University of Toronto. Toronto, Canada. 1983 - 1986

• Clinical Research Fellow Universidad de Toronto

• Diabetes Education University of Manitoba

• Physicians and Surgeons College of Costa Rica cod. MED1629Active

  Medic and Surgeon - Costa Rica

• Medical Certification Committee of CIMA Hospital

• 2017 AACE International Clinician Award 2017

• Head of Endocrinology Service Hospital CIMA

• Mas de 54 publicaciones en revistas nacionales e internacionales.Revisor de articulos sobre dislipidemia de la Revista: Diabetes Obesidad and Metabolism.
• Ex presidente del Capitulo AACE Costa Rica
• Rosen JB; Jiménez JG; Pirags V; Vides H; Hanson M; Massaad R; McPeters G; Joseph Triscari J; Brudi P. A Comparison of Switching to Ezetimibe/Simvastatin (10 mg/20 mg) versus Doubling the Statin Dose to Simvastatin 40 mg or Atorvastatin 20 mg or Switching to Rosuvastatin 10 mg in Patients with Cardiovascular Disease and Diabetes Mellitus. Diab Vasc Dis Res 2013 Jan 3. Rosen et al. Lipids in Health and Disease 2013, 12:103 http://www.lipidworld.com/content/12/1/103
• Jiménez JG, Rosen JB, Pigras V, Massad R, Handson ME, Brudi P, Triscari J. The efficacy and safety of ezetimebe/simvastatin combination compared with intensified lipid-lowerin treatment strategies in diabetic subjects with and without metabolic syndrome. Diabetes, Obesity and Metabolism 2013;15(6):513-1522.
• Jiménez-Montero JG, Gregory Haft. Simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence. Research and Reports in Endocrine Disorders. 2015:5 1–13.
• Gamboa-Gamboa T, Abarca-Soto G, Jiménez-Montero JG. Prevalence of 25-hydroxyvitamin D deficiency in healthy people in the Metropolitan Area in Costa Rica. Research and Reports in Endocrine Disorders. 2015:5 135–140.
• Jiménez.Montero JG Pos-Delivery Hypoglycemia in Type 1 Diabetic Patient is Associated with Lactation: A Case Presentation. http://dx.doi.org/10.18689/MJD1102
• Mechanick JI, Harrel RM, Allende-Vigo M, et al. AACE/ACE Transculturalization Recommendations for Developing Latin American Clinical Practice Algorithms in Endocrinology-Proceedings of the 2015 Pan-American Workshop by the American Association of Clinical Endocrinologists and American College of Endocrinology. Endocrine Practice 2016: 2:476-501.
• Jiménez Montero JG, Cartín Caballero V. Neutropenia severa inducida por propiltiuracilo. AMC 2018; 60:44-46.
• Jiménez-Montero, JG; Mora-Aguilar; Chen-Ku Chih. Diabetic Ketoacidosis in a Patient with Type 1 Diabetes Mellitus Treated with Low Insulin Doses in Combination with Empagliflozin. AACE Clinical Case Rep. 2018;4(No. 6).
• Jiménez-Montero, JG, Moya-Sancho E, Brenes-Pino F, Crespo-Sáenz A, Rivera-Aguerri A. Resistant hypertension in a patient with Primary Aldosteronism due to a suprarenal adenoma. AMC 2019 (No.2, vol 61)
• Jiménez-Montero JG. Diabetic Ketoacidosis Linked with Sodium Glucose Co-Transporter 2 Inhibitors in an Elderly Patient with Type 2 Diabetes. Int J Endocrinol Metab Disord. 2019 5(1): dx.doi.org/10.16966/2380-548X.154
• Jiménez-Montero JG, Hernández-Saborío I, Cob-Sánchez A. Severe Hypoglycemia in an Emergency Department of a General Hospital in Costa Rica. Diabetes & it´s Complications. 2019; 3(2): 1-5.
• Jiménez-Montero JG, Cerdas-Perez S, Ruiz-Salazar F, Yung-Li G, Ulate-Oviedo L, Jiménez-Navarrete M, Calvo-Marin J, Alvayero C and Palencia J. Diabetes Ketoacidosis Linked to Inhibitors of Sodium Glucose Co-Transporters in Diabetic Patients in Central America. Annals of Clinical Diabetes and Endocrinology. 2020; (3):1-5.
• Jimenez-Montero JG, Briceño L. Diabetic Ketoacidosis, Lactic Acidosis and Alcoholic Acidosis in a Type 2 Diabetic Male: Synergic Effects of SGLT-2 Inhibitors with Heavy Alcohol Consumption Int J Clin Med Cases Volume: 3.5 2020.
• Jiménez-Montero JG, Villegas-Barakat M, Cerdas-Salas O. Coto-Hernandez M, Sancho-Ugalde H, MD, Covid-19 in Costa Rica: Achieved goals and imminent risks. Int J Biomed Res Prac, 2020 Volume 1 | Issue 1 | 1 of 4.
• Jiménez-Montero JG, Carvajal-Solorzano ML, Villegas-Barakat M. Reduction of Recurrent Severe Hypoglycemia and Hypoglycemia Unawareness in Type 2 Diabetes by Treatment Modification and Diabetes Education. Diabetes & its Complications 2020; 4(2); 1-7.
• Jiménez-Montero JG, Villegas-Barakat M. Diabetes Mortality in Costa Rica 2007-2017. Diabetes Research and Clinical Practice. 2021;174:108749.
• Villegas-Barakat ML, Jiménez-Montero JG. Análisis provincial de la mortalidad por diabetes en Costa Rica. 2007-2017. Rev ALAD 2021; 110-7.